Picture of Alliance Pharma logo

APH Alliance Pharma Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m-10.31%
3m-6.34%
6m-19.7%
1yr-43.14%
Volume Change (%)
10d/3m+8.81%
Price vs... (%)
52w High-49.34%
50d MA-6.08%
200d MA-12.3%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)8.27
PEG Ratio (f)n/a
EPS Growth (f)-0.22%
Dividend Yield (f)2.54%
Valuation (ttm)IndustryMarket
Price to Book Value0.72
Price to Tang. Bookn/a
Price to Free Cashflow6.94
Price to Sales1.18
EV to EBITDA18.21

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital1.33%
Return on Equity-2.46%
Operating Margin3.64%

Financial Summary

Year End 31st DecUnit201820192020202120222023E2024ECAGR / Avg
Total Revenue£m118.21135.64129.8163.21167.42182.43194.6810.5%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-2.03+7.34-17.09-41.99+60.22+12.33-0.22n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Alliance Pharma EPS forecast chart

Profile Summary

Alliance Pharma plc is a United Kingdom-based consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. The Company's segments are strategic business units that represent different parts of the overall product portfolio, these being Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Changmin, Fazol Cream, Hydromol Ointment, Kelo-Stretch Cream, and others. It holds the marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are sold around the world in more than 100 countries.

Directors

Last Annual
December 31st, 2022
Last Interim
June 30th, 2023
Incorporated
June 26th, 2001
Public Since
November 22nd, 2001
No. of Employees
249
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
540,399,740

APH Share Price Performance

Upcoming Events for APH

Full Year 2023 Alliance Pharma PLC Earnings Call

Full Year 2023 Alliance Pharma PLC Earnings Release

Half Year 2024 Alliance Pharma PLC Earnings Release

Similar to APH

Picture of Animalcare logo

Animalcare

gb flag iconLondon Stock Exchange

Picture of Argent BioPharma logo

Argent BioPharma

gb flag iconLondon Stock Exchange

Picture of AstraZeneca logo

AstraZeneca

gb flag iconLondon Stock Exchange

Picture of Beximco Pharmaceuticals logo

Beximco Pharmaceuticals

gb flag iconLondon Stock Exchange

Picture of BSF Enterprise logo

BSF Enterprise

gb flag iconLondon Stock Exchange

FAQ